Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Proppert Solutions GmbH and Pharma-Labor Yvonne Proppert GmbH are service providers for the German pharmaceutical industry, positioning themselves as offering "consulting services and customised solutions." Rather than a typical SaaS platform, they provide outsourcing and consulting services centered around the R&D, production, marketing, and maintenance of pharmaceuticals and related medical devices, food supplements, and cosmetics, focusing on regulatory affairs, pharmacovigilance, quality systems, and business development.
Their core coverage includes Regulatory Affairs, Pharmacovigilance & Medical Affairs, Quality Assurance/GMP/GDP, and Business Development. Specifically, this encompasses EU marketing authorization applications, lifecycle management, eCTD electronic submissions, xEVMPD, and medical writing and translation. In pharmacovigilance, they provide EU QPPV, Deputy QPPV, German GPO/Stufenplanbeauftragter, PSMF, case assessment, literature review, PSUR, and risk management plans. On the quality side, services involve QP, GDP Responsible Person, manufacturing licenses, batch release, and GMP/GDP quality systems.
The website does not disclose package details, pricing, free tiers, or trial information. Given their mentions of "customised solutions" and "all-inclusive solutions," their business model likely revolves around project-based work, long-term outsourcing, or custom quotes, rather than a standard per-seat SaaS subscription. Payment methods are also unspecified.
The advantage lies in their deep vertical expertise, making them particularly suitable for pharmaceutical companies needing to achieve EU compliance. They can assume key responsibility roles such as EU MAH, virtual EU subsidiary, QPPV, and QP, which is highly attractive to "virtual pharma" companies operating with lean teams. The website also emphasizes their experience since 1984, single point of contact for projects, and project management capabilities. The downside is the lack of transparency regarding software capabilities: there is no mention of third-party integrations, APIs, permission management, cloud deployment, or self-hosting, nor are there any security certifications disclosed. If users are looking for pharmacovigilance SaaS or regulatory submission systems, they need to further verify whether Proppert offers a login-based software product.
It is suitable for pharmaceutical companies planning to launch drugs in the EU, needing post-Brexit EU representative/MAH arrangements, or outsourcing pharmacovigilance systems or GMP/GDP responsible persons, especially SMEs and European business teams of multinational corporations. Access from China is not mentioned on the site and is therefore considered unknown; payments and contracts typically require business negotiation. If a standardized system is needed, alternatives to consider include Veeva Vault, ArisGlobal, Oracle Argus Safety, Ennov, or domestic life science compliance service providers.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on pharma-labor.eu official site.
pharma-labor.eu is an Germany Legal & Tax provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach pharma-labor.eu directly.